Colorectal cancer patients exhibit increased levels of galanin in serum and colon tissues

Kwiatkowski,Przemysław; Godlewski,Janusz; Kieżun,Jacek; Kraziński,Bartłomiej  Emil; Kmieć,Zbigniew

doi:10.3892/ol.2016.5037

Colorectal cancer patients exhibit increased levels of galanin in serum and colon tissues

Authors:
- Przemysław Kwiatkowski
- Janusz Godlewski
- Jacek Kieżun
- Bartłomiej Emil Kraziński
- Zbigniew Kmieć
View Affiliations

Affiliations: Department of Human Histology and Embryology, Faculty of Medical Sciences, University of Warmia and Mazury, 10‑082 Olsztyn, Poland
Published online on: August 23, 2016 https://doi.org/10.3892/ol.2016.5037
Pages: 3323-3329
Copyright: © Kwiatkowski et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Galanin (GAL) is a 30-amino acid neuropeptide that is expressed in both the central and peripheral nervous system, including the enteric nervous system (ENS). Increased GAL concentrations have been identified in the blood of colorectal cancer (CRC) patients. The aim of the present study was to assess whether sections of the colon wall containing ENS plexuses or CRC tumor are associated with increased GAL concentrations. Blood samples were collected from 68 CRC patients and 39 healthy volunteers. In addition, samples of CRC tumors and colon wall tissue in close proximity to and distant from the neoplastic tissue were obtained from 22 CRC patients. The GAL concentration of sera and tissue homogenates obtained from three sections of the colon wall (mucosa with submucosa, muscularis externa and CRC tumor) was analyzed by ELISA. The localization of GAL was evaluated using immunohistochemistry and morphometry was used to measure the distribution of GAL‑immunoreactive (GAL‑Ir) myenteric plexuses in the vicinity of cancer invasion and in sections of the colon wall distant from the tumor. The GAL serum concentration of CRC patients was 2.4 times higher than that of the control group. The GAL concentration was highest in the homogenates of neoplastic tissue and mucosa obtained from the control (distant) section of the intestinal wall, followed by that in the mucosa and muscularis externa proximal to the tumor. The lowest GAL concentrations were identified within the muscular layer of the colon wall located distant from the tumor. Strong GAL immunoreactivity was identified in the cancer cells, intestinal epithelium and the submucosal and myenteric plexuses. Morphometric analysis revealed that the GAL‑Ir myenteric plexuses in the vicinity of tumor infiltration were significantly smaller in size than those in the intact section of the large intestine. Furthermore, no associations were identified between the clinicopathological characteristics of CRC patients and GAL serum and tissue concentration. The increased GAL serum concentrations observed in CRC patients in comparison to healthy controls may result from GAL secretion by CRC tumors, however, other sources of GAL cannot be excluded. The atrophy of myenteric plexuses within close proximity to the tumor may affect the colon function of CRC patients. In conclusion, investigation into the presence of GAL in the colon wall and serum of CRC patients revealed that serum and tissue GAL levels may present useful potential biomarkers in CRC patients.

View Figures

View References

1	Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013 http://globocan.iarc.frJanuary 16–2015
2	Keane MG and Johnson GJ: Early diagnosis improves survival in colorectal cancer. Practitioner. 256:15–18. 2012.PubMed/NCBI
3	Chen H, Zucknick M, Werner S, Knebel P and Brenner H: Head-to-head comparison and evaluation of 92 plasma protein biomarkers for early detection of colorectal cancer in a true screening setting. Clin Cancer Res. 21:3318–3326. 2015. View Article : Google Scholar : PubMed/NCBI
4	Gonzalez-Pons M and Cruz-Correa M: Colorectal cancer biomarkers: Where are we now? Biomed Res Int. 2015:1490142015. View Article : Google Scholar : PubMed/NCBI
5	Mitsukawa K, Lu X and Bartfai T: Galanin, galanin receptorss, and drug targetsGalanin. Hökfelt T: 102. Springer; Basel: pp. 7–9. 2010, View Article : Google Scholar
6	Burleigh DE and Furness JB: Distribution and actions of galanin and vasoactive intestinal peptide in the human colon. Neuropeptides. 16:77–82. 1990. View Article : Google Scholar : PubMed/NCBI
7	von Rosenvinge EC and Raufman JP: Gastrointestinal peptides and regulation of gastric acid secretion. Curr Opin Endocrinol Diabetes Obes. 17:40–43. 2010. View Article : Google Scholar : PubMed/NCBI
8	Barreto SG, Carati CJ, Toouli J and Saccone GT: The islet-acinar axis of the pancreas: More than just insulin. Am J Physiol Gastrointest Liver Physiol. 299:G10–G22. 2010. View Article : Google Scholar : PubMed/NCBI
9	Bauer FE, Hacker GW, Terenghi G, Adrian TE, Polak JM and Bloom SR: Localization and molecular forms of galanin in human adrenals: Elevated levels in pheochromocytomas. J Clin Endocrinol Metab. 63:1372–1378. 1986. View Article : Google Scholar : PubMed/NCBI
10	Grenbäck E, Bjellerup P, Wallerman E, Lundblad L, Anggård A, Ericson K, Aman K, Landry M, Schmidt WE, Hökfelt T and Hulting AL: Galanin in pituitary adenomas. Regul Pept. 117:127–139. 2004. View Article : Google Scholar : PubMed/NCBI
11	Tuechler C, Hametner R, Jones N, Jones R, Iismaa TP, Sperl W and Kofler B: Galanin and galanin receptor expression in neuroblastoma. Ann NY Acad Sci. 863:438–441. 1998. View Article : Google Scholar : PubMed/NCBI
12	Sugimoto T, Seki N, Shimizu S, Kikkawa N, Tsukada J, Shimada H, Sasaki K, Hanazawa T, Okamoto Y and Hata A: The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma. Genes Chromosomes Cancer. 48:132–142. 2009. View Article : Google Scholar : PubMed/NCBI
13	Gilaberte Y, Vera J, Coscojuela C, Roca MJ, Parrado C and González S: Expression of galanin in melanocytic tumors. Actas Dermosifiliogr. 98:24–34. 2007.(In Spanish). View Article : Google Scholar : PubMed/NCBI
14	Kim KY, Kee MK, Chong SA and Nam MJ: Galanin is up-regulated in colon adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 16:2373–2378. 2007. View Article : Google Scholar : PubMed/NCBI
15	Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, Vernon SW, Cronin K and Edwards BK: The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer. 88:2398–2424. 2000. View Article : Google Scholar : PubMed/NCBI
16	Godlewski J and Łakomy IM: Changes in vasoactive intestinal peptide, pituitary adenylate cyclase- activating polypeptide and neuropeptide Y-ergic structures of the enteric nervous system in the carcinoma of the human large intestine. Folia Histochem Cytobiol. 48:208–216. 2010. View Article : Google Scholar : PubMed/NCBI
17	Godlewski J and Pidsudko Z: Characteristic of galaninergic components of the enteric nervous system in the cancer invasion of human large intestine. Ann Anat. 194:368–372. 2012. View Article : Google Scholar : PubMed/NCBI
18	Godlewski J: Morphological changes in the enteric nervous system caused by carcinoma of the human large intestine. Folia Histochem Cytobiol. 48:157–162. 2010. View Article : Google Scholar : PubMed/NCBI
19	Godlewski J, Krazinski BE, Kiezun J, Kwiatkowski P, Sulik M, Tenderenda M, Biernat W and Kmiec Z: PLAGL1 protein is differentially expressed in the nephron segments and collecting ducts in human kidney. Folia Histochem Cytobiol. 53:96–104. 2015. View Article : Google Scholar : PubMed/NCBI
20	Furness JB: Structure of the enteric nervous systemThe Enteric Nervous System. Wiley-Blackwell; Hoboken, NJ: pp. 62006
21	Nagayoshi K, Ueki T, Tashiro K, Mizuuchi Y, Manabe T, Araki H, Oda Y, Kuhara S and Tanaka M: Galanin plays an important role in cancer invasiveness and is associated with poor prognosis in stage II colorectal cancer. Oncol Rep. 33:539–546. 2015.PubMed/NCBI
22	Tadros TS, Strauss RM, Cohen C and Gal AA: Galanin immunoreactivity in paragangliomas but not in carcinoid tumors. Appl Immunohistochem Mol Morphol. 11:250–252. 2003. View Article : Google Scholar : PubMed/NCBI
23	Berger A, Santic R, Almer D, Hauser-Kronberger C, Huemer M, Humpel C, Stockhammer G, Sperl W and Kofler B: Galanin and galanin receptors in human gliomas. Acta Neuropathol. 105:555–560. 2003.PubMed/NCBI
24	Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fosså SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW and Lothe RA: Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res. 65:5588–5598. 2005. View Article : Google Scholar : PubMed/NCBI
25	Benya RV, Marrero JA, Ostrovskiy DA, Koutsouris A and Hecht G: Human colonic epithelial cells express galanin-1 receptors, which when activated cause Cl- secretion. Am J Physiol. 276:G64–G72. 1999.PubMed/NCBI
26	Lang R, Gundlach AL, Holmes FE, Hobson SA, Wynick D, Hökfelt T and Kofler B: Physiology, signaling and pharmacology of galanin peptides and receptors: Three decades of emerging diversity. Pharmacol Rev. 67:118–175. 2015. View Article : Google Scholar : PubMed/NCBI
27	Kofler B, Berger A, Santic R, Moritz K, Almer D, Tuechler C, Lang R, Emberger M, Klausegger A, Sperl W and Bauer JW: Expression of neuropeptide galanin and galanin receptors in human skin. J Invest Dermatol. 122:1050–1053. 2004. View Article : Google Scholar : PubMed/NCBI
28	Stevenson L, Allen WL, Turkington R, Jithesh PV, Proutski I, Stewart G, Lenz HJ, Van Schaeybroeck S, Longley DB and Johnston PG: Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancer. Clin Cancer Res. 18:5412–5426. 2012. View Article : Google Scholar : PubMed/NCBI
29	Tjomsland V and El-Salhy M: Effects of single, double or triple combinations of octreotide, galanin and serotonin on a human pancreatic cancer cell line. Histol Histopathol. 20:537–541. 2005.PubMed/NCBI
30	Seufferlein T and Rozengurt E: Galanin, neurotensin, and phorbol esters rapidly stimulate activation of mitogen-activated protein kinase in small cell lung cancer cells. Cancer Res. 56:5758–5764. 1996.PubMed/NCBI
31	Hammond PJ, Smith DM, Akinsanya KO, Mufti WA, Wynick D and Bloom SR: Signaling pathways mediating secretory and mitogenic responses to galanin and pituitary adenylate cyclase-activating polypeptide in the 235-1 clonal rat lactotroph cell line. J Neuroendocrinol. 8:457–464. 1996. View Article : Google Scholar : PubMed/NCBI
32	Kanazawa T, Misawa K, Misawa Y, Uehara T, Fukushima H, Kusaka G, Maruta M and Carey TE: G-protein-coupled receptors: Next generation therapeutic targets in head and neck cancer? Toxins (Basel). 7:2959–2984. 2015. View Article : Google Scholar : PubMed/NCBI